Barrow, Hanley, Mewhinney & Strauss’s Sanofi SNY Stock Holding History

Barrow, Hanley, Mewhinney & Strauss’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$284M	Sell	5,887,466 -1,080,947	-16%	-$50.4M	0.93%	40
2025 Q4	$338M	Sell	6,968,413 -158,580	-2%	-$7.86M	1.12%	36
2025 Q3	$336M	Sell	7,126,993 -153,543	-2%	-$7.41M	1.07%	41
2025 Q2	$352M	Sell	7,280,536 -68,909	-0.9%	-$3.52M	1.19%	34
2025 Q1	$408M	Sell	7,349,445 -347,844	-5%	-$18.8M	1.48%	24
2024 Q4	$371M	Sell	7,697,289 -140,540	-2%	-$7.15M	1.26%	29
2024 Q3	$452M	Buy	7,837,829 +1,894,282	+32%	+$102M	1.48%	25
2024 Q2	$288M	Buy	5,943,547 +3,164,092	+114%	+$153M	0.98%	39
2024 Q1	$135M	Buy	+2,779,455	New	+$136M	0.45%	59
2022 Q2	–	Sell	-59,678	Closed	-$3.06M	–	332
2022 Q1	$3.06M	Sell	59,678 -10,620	-15%	-$548K	0.01%	139
2021 Q4	$3.52M	Hold	70,298	–	–	0.01%	149
2021 Q3	$3.39M	Sell	70,298 -1,742	-2%	-$88.6K	0.01%	149
2021 Q2	$3.79M	Sell	72,040 -4,388	-6%	-$229K	0.01%	149
2021 Q1	$3.78M	Hold	76,428	–	–	0.01%	152
2020 Q4	$3.71M	Sell	76,428 -1,035	-1%	-$51K	0.01%	149
2020 Q3	$3.89M	Sell	77,463 -21,859	-22%	-$1.13M	0.02%	141
2020 Q2	$5.07M	Sell	99,322 -512,972	-84%	-$24.9M	0.02%	137
2020 Q1	$26.8M	Sell	612,294 -471,278	-43%	-$22.5M	0.12%	106
2019 Q4	$54.4M	Sell	1,083,572 -9,354,695	-90%	-$438M	0.17%	105
2019 Q3	$484M	Sell	10,438,267 -2,966,281	-22%	-$128M	0.95%	35
2019 Q2	$580M	Sell	13,404,548 -9,172,732	-41%	-$390M	1.06%	32
2019 Q1	$1,000M	Buy	22,577,280 +110,258	+0.5%	+$4.72M	1.8%	22
2018 Q4	$975M	Buy	22,467,022 +2,039,820	+10%	+$90M	1.91%	20
2018 Q3	$912M	Buy	20,427,202 +954,977	+5%	+$40.8M	1.45%	29
2018 Q2	$779M	Sell	19,472,225 -2,152,785	-10%	-$84.8M	1.26%	31
2018 Q1	$867M	Sell	21,625,010 -753,807	-3%	-$31.4M	1.38%	31
2017 Q4	$962M	Sell	22,378,817 -1,587,732	-7%	-$73.2M	1.44%	30
2017 Q3	$1.19B	Sell	23,966,549 -1,340,207	-5%	-$64.9M	1.8%	26
2017 Q2	$1.21B	Sell	25,306,756 -4,111,725	-14%	-$197M	1.84%	23
2017 Q1	$1.33B	Buy	29,418,481 +41,335	+0.1%	+$1.75M	2%	17
2016 Q4	$1.19B	Sell	29,377,146 -1,943,181	-6%	-$76.6M	1.78%	22
2016 Q3	$1.2B	Buy	31,320,327 +3,198,048	+11%	+$128M	1.82%	24
2016 Q2	$1.18B	Sell	28,122,279 -965,511	-3%	-$39.6M	1.79%	21
2016 Q1	$1.17B	Sell	29,087,790 -401,578	-1%	-$16.1M	1.79%	21
2015 Q4	$1.26B	Buy	29,489,368 +365,804	+1%	+$16.8M	1.87%	20
2015 Q3	$1.38B	Sell	29,123,564 -837,643	-3%	-$42.7M	2.13%	9
2015 Q2	$1.48B	Sell	29,961,207 -264,014	-0.9%	-$13.4M	2.02%	13
2015 Q1	$1.49B	Sell	30,225,221 -579,238	-2%	-$27.7M	2.03%	13
2014 Q4	$1.4B	Buy	30,804,459 +2,510,736	+9%	+$122M	1.88%	20
2014 Q3	$1.6B	Sell	28,293,723 -233,079	-0.8%	-$12.5M	2.18%	12
2014 Q2	$1.52B	Buy	28,526,802 +736,686	+3%	+$39.1M	2.04%	15
2014 Q1	$1.45B	Buy	27,790,116 +5,144,976	+23%	+$260M	2.08%	13
2013 Q4	$1.21B	Buy	22,645,140 +1,178,152	+5%	+$60.8M	1.76%	23
2013 Q3	$1.09B	Buy	21,466,988 +16,267,469	+313%	+$828M	1.74%	23
2013 Q2	$268M	Buy	+5,199,519	New	+$277M	0.45%	50

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss's SNY Position: Q1 2026 in Review

Barrow, Hanley, Mewhinney & Strauss reduced its Sanofi (SNY) stake by 16% in Q1 2026, selling an estimated $50.4M and leaving 5,887,466 shares worth $284M. The position accounts for 0.93% of the portfolio, ranked #40.

Barrow, Hanley, Mewhinney & Strauss first reported a position in SNY in Q2 2013 and has held it in 45 quarters since. The position peaked at $1.6B in Q3 2014. 739 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

Barrow, Hanley, Mewhinney & Strauss held 5,887,466 shares of Sanofi worth $284M as of Q1 2026.
Barrow, Hanley, Mewhinney & Strauss sold 1,080,947 Sanofi shares in Q1 2026, an estimated $50.4M.
Sanofi made up 0.93% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q1 2026, its #40 holding.
Barrow, Hanley, Mewhinney & Strauss first reported a position in Sanofi in Q2 2013 and has held it in 45 quarters since.
Barrow, Hanley, Mewhinney & Strauss's Sanofi position peaked at $1.6B in Q3 2014.
739 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q1 2026, filed 13 May 2026.